CAPLIPOINT
Caplin Point Laboratories Limited
Healthcare
Share price
₹2,561
Market cap
₹19,445 Cr
1Y return
▲ 16%
A pharmaceutical manufacturer engaged in producing active pharmaceutical ingredients and finished formulations with integrated research and development capabilities. Caplin Point Laboratories operates across multiple geographies including Latin America, Africa, and the United States, serving both domestic and international markets. The company combines API manufacturing with clinical research operations, positioning itself as a vertically integrated player in the global healthcare sector with a diverse product portfolio.
Investors holding Caplin Point Laboratories Limited
2.87%
Latest move
Indian GovernmentDecreased
The Indian Government decreased its stake in Caplin Point Laboratories from 3.04% to 2.87%, selling 1,31,167 shares. The value of the shares sold is approximately ₹32.79 Cr at ₹2499.70 apiece.
Sign in to read more
Whales made 1 more move in Caplin Point Laboratories Limited
Sign in to see who is buying and selling.
Sign in to find out